Evidence map›Paper›PMID 41954638›Full record

ArticleExperimental brain research2026

Parkinson's disease dementia and hearing impairment, are they related? A UK biobank pilot analysis.

Megan Rose Readman, Clarissa Giebel, Jacqui Cannon, Ian Fairman, Christopher J Plack

Abstract read
In one paragraph

Article in Experimental brain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Megan Rose ReadmanDepartment of Primary Care and Mental Health, The University of Liverpool, Waterhouse Building Block B, 2 Floor, Liverpool, L69 3GL, UK. m.readman@liverpool.ac.uk.
Clarissa GiebelDepartment of Primary Care and Mental Health, The University of Liverpool, Waterhouse Building Block B, 2 Floor, Liverpool, L69 3GL, UK.
Jacqui CannonNational Institute for Health and Care Research Applied Research Collaboration North West Coast, Liverpool, UK.
Ian FairmanNational Institute for Health and Care Research Applied Research Collaboration North West Coast, Liverpool, UK.
Christopher J PlackDepartment of Psychology, Lancaster University, Lancaster, UK.

Funding

Manchester Biomedical Research Centre NIHR203308
6 · The paper itself

Abstract

Hearing impairment is implicated as a risk factor for the incidence of all-cause dementia. However, few studies have explored the relationship between hearing loss and specific rarer dementia subtypes. Therefore, this pilot study sought to explore whether hearing impairment, estimated using a speech-in-noise test (the digit triplet test, DTT), is a risk factor for Parkinson’s disease dementia (PDD) incidence. We conducted a pre-registered prospective cohort study using UK Biobank data from 158,686 individuals (72,015 males; 86,671 females), who underwent the DTT, and were free from PDD at the point of assessment. A Cox Proportional Hazard model, controlling for age, sex and educational attainment was conducted. Over a median follow-up of 8.93 years (SD = 2.29), 101 cases of incident PDD were observed. While the hazard ratio were in the direction of a positive relationship between baseline DTT and PDD incidence, imprecision in estimates leaves it uncertain as to whether risk was influenced by speech-reception-threshold (HR = 2.39, 95% CI: 0.75,7.63; p = .141), and findings should be treated as exploratory. An exploratory analysis, in which speech-reception-thresholds were categorised according to UK Biobank norms, showed that ‘insufficient’ (p = .024), but not ‘poor’ (p = .236) hearing increased PDD risk. The observed HR directionally aligns with the previously observed positive relationship between hearing loss and all-cause dementia incidence. However, further studies employing alternative datasets with more PDD cases are required to substantiate these findings. If further supported, these findings may have clinical and public health implications.

Indexed as

DementiaHearing LossParkinson DiseaseAgedBiological Specimen BanksCohort StudiesFemaleHumansIncidenceMaleMiddle AgedPilot ProjectsProspective StudiesRisk FactorsUK BiobankUnited KingdomDementiaHearing lossParkinson’s disease dementiaRisk

Identifiers

PMID41954638
PMCPMC13065560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.